Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436

Watchlist Manager
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Logo
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Watchlist
Price: 236 CNY -4.49% Market Closed
Market Cap: 142.4B CNY
Have any thoughts about
Zhangzhou Pientzehuang Pharmaceutical Co Ltd?
Write Note

Zhangzhou Pientzehuang Pharmaceutical Co Ltd
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Zhangzhou Pientzehuang Pharmaceutical Co Ltd
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Gross Profit
ÂĄ4.8B
CAGR 3-Years
13%
CAGR 5-Years
17%
CAGR 10-Years
21%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Gross Profit
ÂĄ9.1B
CAGR 3-Years
5%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Gross Profit
ÂĄ22.1B
CAGR 3-Years
-4%
CAGR 5-Years
3%
CAGR 10-Years
14%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Gross Profit
ÂĄ10.5B
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
8%
C
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
Gross Profit
ÂĄ849.6m
CAGR 3-Years
9%
CAGR 5-Years
6%
CAGR 10-Years
N/A
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Gross Profit
ÂĄ319.6m
CAGR 3-Years
-27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Zhangzhou Pientzehuang Pharmaceutical Co Ltd
Glance View

Market Cap
142.4B CNY
Industry
Pharmaceuticals

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. is a beacon of traditional Chinese medicine, rooted in a legacy that dates back over four decades. Specializing in the production of proprietary herbal medicines, particularly its flagship product, Pientzehuang, the company expertly marries ancient healing practices with modern pharmaceutical standards. The company's commitment to quality and innovation is evident in its meticulous sourcing of raw materials and rigorous R&D efforts, positioning it as a leader in the herbal medicine sector. Zhangzhou's extensive distribution network spans both domestic and international markets, enhancing its brand recognition and further entrenching its products in the hearts and homes of patients seeking natural remedies. As the global demand for alternative healthcare solutions continues to rise, Zhangzhou Pientzehuang stands at the forefront of this burgeoning market. The company's unwavering focus on expanding its product line and leveraging e-commerce platforms provides lucrative opportunities for growth. Additionally, its strategic partnerships with healthcare institutions and researchers underscore its credibility and commitment to advancing healthcare. For investors, Zhangzhou Pientzehuang represents not merely an investment in a company, but a stake in the revival and global acceptance of traditional Chinese medicine, a field that resonates with the increasing emphasis on holistic health and wellness. With a robust business model and a future poised for expansion, the company stands as an attractive candidate for those looking to invest in the convergence of tradition and modern healthcare innovation.

Intrinsic Value
162.22 CNY
Overvaluation 31%
Intrinsic Value
Price

See Also

What is Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Gross Profit?
Gross Profit
4.8B CNY

Based on the financial report for Jun 30, 2024, Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Gross Profit amounts to 4.8B CNY.

What is Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Gross Profit growth rate?
Gross Profit CAGR 10Y
21%

Over the last year, the Gross Profit growth was 15%. The average annual Gross Profit growth rates for Zhangzhou Pientzehuang Pharmaceutical Co Ltd have been 13% over the past three years , 17% over the past five years , and 21% over the past ten years .

Back to Top